You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mantle Cell Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • +7 more
  • (no location specified)
Jun 21, 2022

Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

Completed
  • Multiple Myeloma
  • +11 more
  • Pre-biotic foods/drinks
  • Charlottesville, Virginia
    University of Virginia
Jan 2, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Seattle (Nivolumab)

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +17 more
  • Nivolumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 13, 2022

Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle

Not yet recruiting
  • Post-Transplant Lymphoproliferative Disorder
  • +10 more
  • Loncastuximab Tesirine
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2022

Blastoid Variant Mantle Cell Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Follicular Lymphoma Trial in United

Active, not recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +8 more
  • Birmingham, Alabama
  • +4 more
May 10, 2022

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

    Withdrawn
    • Asymptomatic COVID-19 Infection Laboratory-Confirmed
    • +8 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 2, 2022

    Mantle Cell Lymphoma Trial in Miami, Houston (Zanubrutinib, Tafasitamab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Miami, Florida
    • +1 more
    Aug 31, 2023

    Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

    Not yet recruiting
    • Lymphoma, Mantle-Cell
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Nov 14, 2023

    Grade 3a Follicular Lymphoma, Recurrent Burkitt Lymphoma, Recurrent DLBCL Trial in Atlanta, Columbus (other, drug, biological)

    Recruiting
    • Grade 3a Follicular Lymphoma
    • +14 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Atlanta, Georgia
    • +1 more
    May 31, 2022

    Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

    Active, not recruiting
    • Acute Leukemia
    • +14 more
    • Duarte, California
      City of Hope Medical Center
    Nov 18, 2022

    CD20+, B-cell Lymphomas, Mantle Cell Lymphoma, Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) Trial in Baltimore

    Completed
    Has Results
    • CD20+, B-cell Lymphomas
    • +5 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Oct 4, 2021

    Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)

    Recruiting
    • Blastoid Variant Mantle Cell Lymphoma
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

    Completed
    Has Results
    • Mantle Cell Lymphoma
    • Lymphoma, Mantle Cell
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 4, 2023

    Patient Perspectives in Mantle Cell Lymphoma Clinical Research

    Not yet recruiting
    • Mantle Cell Lymphoma
      • San Francisco, California
        Power Life Sciences
      Sep 15, 2023

      Mantle Cell Lymphoma Trial (Zanubrutinib, Rituximab)

      Not yet recruiting
      • Mantle Cell Lymphoma
      • (no location specified)
      Nov 22, 2022

      Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)

      Recruiting
      • Recurrent Mantle Cell Lymphoma
      • Refractory Mantle Cell Lymphoma
      • Low Dose Radiation Therapy
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 30, 2023

      Mantle Cell Lymphoma Trial (Acalabrutinib, Rituximab)

      Not yet recruiting
      • Mantle Cell Lymphoma
      • (no location specified)
      Oct 31, 2022

      HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

      Recruiting
      • HIV Infection
      • +10 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • +7 more
      • La Jolla, California
      • +3 more
      Dec 7, 2022

      Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory Trial (Glofitamab, Pirtobrutinib, Obinutuzumab)

      Not yet recruiting
      • Mantle Cell Lymphoma
      • Mantle Cell Lymphoma Refractory
      • (no location specified)
      Apr 18, 2023

      Chronic Lymphocytic Leukemia, Chronic Graft-versus-host-disease, Mantle Cell Lymphoma Trial in Poland (Acalabrutinib 2x100 MG

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +4 more
      • Acalabrutinib 2x100 MG Oral Capsule + alloSCT
      • Warszawa, Mazowieckie, Poland
      • +5 more
      Dec 23, 2021

      Mantle Cell Lymphoma Trial (drug, biological, other, procedure)

      Not yet recruiting
      • Mantle Cell Lymphoma
      • (no location specified)
      Jul 26, 2023

      Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

      Not yet recruiting
      • Blastoid Variant Mantle Cell Lymphoma
      • +2 more
      • Biopsy
      • +8 more
      • Duarte, California
        City of Hope Medical Center
      May 15, 2023

      Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

      Recruiting
      • Lymphoma
      • Beijing, China
      • +2 more
      Oct 12, 2023